Article
Irvine, CA—Allergan Inc. celebrated the opening of its new $60 million Herbert Research Center here in December. Touted as a state-of-the-art facility to study eye disease and neurologic disorders, the center will house areas for molecular biology, neuromodulator research, high-throughput screening, and medicinal chemistry.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.